International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Survivorship
Issam Raad, Ray Hachem, Nigo Masayuki, Tarcila Datoguia, Hiba Dagher, Ying Jiang, View ORCID ProfileVivek Subbiah, Bilal Siddiqui, Arnaud Bayle, Robert Somer, Ana Fernández Cruz, Edward Gorak, Arvinder Bhinder, Nobuyoshi Mori, Nelson Hamerschlak, Samuel Shelanski, Tomislav Dragivich, Yee Elise Vong Kiat, Suha Fakhreddine, Pierre Abi Hanna, Roy F. Chemaly, Victor Mulanovich, Javier Adachi, Jovan Borjan, Fareed Khawaja, Bruno Granwehr, Teny John, Eduardo Yepez Guevara, Harrys Torres, Natraj Reddy Ammakkanavar, Marcel Yibirin, Cielito C Reyes-Gibby, Mala Pande, Noman Ali, Raniv Dawey Rojo, Shahnoor M Ali, Rita E Deeba, Patrick Chaftari, Takahiro Matsuo, Kazuhiro Ishikawa, Ryo Hasegawa, Ramón Aguado-Noya, Álvaro García-García, Cristina Traseira Puchol, Dong-Gun Lee, Monica Slavin, View ORCID ProfileBenjamin Teh, Cesar A Arias, Data-Driven Determinants for COVID-19 Oncology Discovery Effort (D3CODE) Team, Dimitrios P. Kontoyiannis, Alexandre E. Malek, View ORCID ProfileAnne-Marie Chaftari
doi: https://doi.org/10.1101/2022.08.25.22279181
Issam Raad
1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Ray Hachem
1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Nigo Masayuki
2Division of Infectious Diseases, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA
Tarcila Datoguia
3Médica Hematologista Hospital Israelita Albert Einstein, São Paulo, Brasil
Hiba Dagher
1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Ying Jiang
1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Vivek Subbiah
4Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
5MD Anderson Cancer Network, UT MD Anderson Cancer Center, Houston, Texas, USA
Bilal Siddiqui
6Department of Hematology Oncology, Community Health Network, Indiana, USA
Arnaud Bayle
7Department of Medical Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France
Robert Somer
8Cooper Medical School of Rowan University, Cooper University Health Care, Camden, New Jersey, USA
Ana Fernández Cruz
9Unidad de Enfermedades Infecciosas, Servicio de Medicina Interna, Hospital Universitario Puerta de Hierro, Madrid, Spain
Edward Gorak
10Department of Hematology Oncology, Baptist Health, Jacksonville, Florida, USA
Arvinder Bhinder
11Department of Hematology/Oncology, Ohio Health Marion, Ohio, USA
Nobuyoshi Mori
12Department of Infectious Diseases, St. Luke’s International Hospital, Tokyo, Japan
Nelson Hamerschlak
3Médica Hematologista Hospital Israelita Albert Einstein, São Paulo, Brasil
Samuel Shelanski
13Banner MD Anderson Cancer Center – North Colorado, Greely, Colorado, USA
Tomislav Dragivich
14Division of Cancer Medicine, Banner MD Anderson Cancer Center, Gilbert, Arizona, USA
Yee Elise Vong Kiat
15Department of Medical Oncology, Tan Tock Seng Hospital, Singapore
Suha Fakhreddine
16Department of Infectious Diseases, Rafik Hariri University Hospital, Beirut, Lebanon
Pierre Abi Hanna
16Department of Infectious Diseases, Rafik Hariri University Hospital, Beirut, Lebanon
Roy F. Chemaly
1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Victor Mulanovich
1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Javier Adachi
1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Jovan Borjan
1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Fareed Khawaja
1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Bruno Granwehr
1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Teny John
1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Eduardo Yepez Guevara
1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Harrys Torres
1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Natraj Reddy Ammakkanavar
4Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Marcel Yibirin
1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Cielito C Reyes-Gibby
17Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Mala Pande
18Department of Gastroenterology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Noman Ali
19Department of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Raniv Dawey Rojo
20Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Shahnoor M Ali
1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Rita E Deeba
1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Patrick Chaftari
17Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Takahiro Matsuo
12Department of Infectious Diseases, St. Luke’s International Hospital, Tokyo, Japan
Kazuhiro Ishikawa
12Department of Infectious Diseases, St. Luke’s International Hospital, Tokyo, Japan
Ryo Hasegawa
12Department of Infectious Diseases, St. Luke’s International Hospital, Tokyo, Japan
Ramón Aguado-Noya
21Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain
Álvaro García-García
22Hematology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain
Cristina Traseira Puchol
21Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain
Dong-Gun Lee
23Division of Infectious Diseases, Department of Internal Medicine, Vaccine Bio Research Institute, The Catholic University of Korea, Seoul, Korea
Monica Slavin
24Department of Infectious Diseases and National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Benjamin Teh
24Department of Infectious Diseases and National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Cesar A Arias
2Division of Infectious Diseases, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA
25Data-Driven Determinants for COVID-19 Oncology Discovery Effort (D3CODE) Team at The University of Texas MD Anderson Cancer Center, Houston, TX
Dimitrios P. Kontoyiannis
1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Alexandre E. Malek
1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Anne-Marie Chaftari
1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
The study protocol, statistical analysis plan, lists of deidentified individual data, generated tables and figures will be made available upon request by qualified scientific and medical researchers for legitimate research purposes. Requests should be sent to achaftari{at}mdanderson.org and yijiang{at}mdanderson.org. Data will be available on request for 6 months from the date of publication. Investigators are invited to submit study proposal requests detailing research questions and hypotheses in order to receive access to these data.
Posted August 26, 2022.
International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Survivorship
Issam Raad, Ray Hachem, Nigo Masayuki, Tarcila Datoguia, Hiba Dagher, Ying Jiang, Vivek Subbiah, Bilal Siddiqui, Arnaud Bayle, Robert Somer, Ana Fernández Cruz, Edward Gorak, Arvinder Bhinder, Nobuyoshi Mori, Nelson Hamerschlak, Samuel Shelanski, Tomislav Dragivich, Yee Elise Vong Kiat, Suha Fakhreddine, Pierre Abi Hanna, Roy F. Chemaly, Victor Mulanovich, Javier Adachi, Jovan Borjan, Fareed Khawaja, Bruno Granwehr, Teny John, Eduardo Yepez Guevara, Harrys Torres, Natraj Reddy Ammakkanavar, Marcel Yibirin, Cielito C Reyes-Gibby, Mala Pande, Noman Ali, Raniv Dawey Rojo, Shahnoor M Ali, Rita E Deeba, Patrick Chaftari, Takahiro Matsuo, Kazuhiro Ishikawa, Ryo Hasegawa, Ramón Aguado-Noya, Álvaro García-García, Cristina Traseira Puchol, Dong-Gun Lee, Monica Slavin, Benjamin Teh, Cesar A Arias, Data-Driven Determinants for COVID-19 Oncology Discovery Effort (D3CODE) Team, Dimitrios P. Kontoyiannis, Alexandre E. Malek, Anne-Marie Chaftari
medRxiv 2022.08.25.22279181; doi: https://doi.org/10.1101/2022.08.25.22279181
International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Survivorship
Issam Raad, Ray Hachem, Nigo Masayuki, Tarcila Datoguia, Hiba Dagher, Ying Jiang, Vivek Subbiah, Bilal Siddiqui, Arnaud Bayle, Robert Somer, Ana Fernández Cruz, Edward Gorak, Arvinder Bhinder, Nobuyoshi Mori, Nelson Hamerschlak, Samuel Shelanski, Tomislav Dragivich, Yee Elise Vong Kiat, Suha Fakhreddine, Pierre Abi Hanna, Roy F. Chemaly, Victor Mulanovich, Javier Adachi, Jovan Borjan, Fareed Khawaja, Bruno Granwehr, Teny John, Eduardo Yepez Guevara, Harrys Torres, Natraj Reddy Ammakkanavar, Marcel Yibirin, Cielito C Reyes-Gibby, Mala Pande, Noman Ali, Raniv Dawey Rojo, Shahnoor M Ali, Rita E Deeba, Patrick Chaftari, Takahiro Matsuo, Kazuhiro Ishikawa, Ryo Hasegawa, Ramón Aguado-Noya, Álvaro García-García, Cristina Traseira Puchol, Dong-Gun Lee, Monica Slavin, Benjamin Teh, Cesar A Arias, Data-Driven Determinants for COVID-19 Oncology Discovery Effort (D3CODE) Team, Dimitrios P. Kontoyiannis, Alexandre E. Malek, Anne-Marie Chaftari
medRxiv 2022.08.25.22279181; doi: https://doi.org/10.1101/2022.08.25.22279181
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (671)
- Anesthesia (181)
- Cardiovascular Medicine (2655)
- Dermatology (224)
- Emergency Medicine (400)
- Epidemiology (12248)
- Forensic Medicine (10)
- Gastroenterology (763)
- Genetic and Genomic Medicine (4113)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2665)
- Health Policy (1005)
- Hematology (364)
- HIV/AIDS (853)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (439)
- Neurology (3897)
- Nursing (210)
- Nutrition (578)
- Oncology (2037)
- Ophthalmology (586)
- Orthopedics (241)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1116)
- Primary Care Research (452)
- Public and Global Health (6538)
- Radiology and Imaging (1407)
- Respiratory Medicine (871)
- Rheumatology (411)
- Sports Medicine (343)
- Surgery (451)
- Toxicology (53)
- Transplantation (185)
- Urology (166)